BIOPHYTIS - Live Healthier Longer
Aging process therapeutics development
- B2B
About BIOPHYTIS - Live Healthier Longer
Clinical-stage biotechnology company developing small molecules to slow aging processes, with leading drug candidate Ruvembri targeting COVID-19, sarcopenia, and Duchenne Muscular Dystrophy
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- paris, Île-de-France, France
- Founded
- 2006
- Revenue
- $5.5M – $43MTamtam estimate
- Website
- biophytis.com
- linkedin.com/company/biophytis
BIOPHYTIS - Live Healthier Longer at a glance
BIOPHYTIS - Live Healthier Longer is a B2B company in the Biotechnology industry, headquartered in paris, Île-de-France, France.
BIOPHYTIS - Live Healthier Longer was founded in 2006.
BIOPHYTIS - Live Healthier Longer has 11–50 employees.
BIOPHYTIS - Live Healthier Longer's revenue is $5.5M – $43M (Tamtam estimate).
Selling to companies like BIOPHYTIS - Live Healthier Longer?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies